Why Pfizer’s Shares Are Slipping 7.6% Today

    0
    81
    Why Pfizer’s Shares Are Slipping 7.6% Today

    What happened
    Shares are tumbling after Pfizer(NYSE:PFE) reported that its breast cancer drug, Ibrance, came up shy in a phase 3 trial evaluating its use alongside adjuvant endocrine therapy in earl…
    Read More

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here